Blacklane vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Blacklane

GrowthTravel & Hospitality

Ground Transportation

Premium global chauffeur platform; $65M Series G raised Oct 2024; ~$75M annual revenue. Acquired by Uber in March 2026. 50+ countries, 100K+ rides/month.

About

Blacklane is a Berlin-based premium chauffeur booking platform founded in 2011 by Jens Wohltorf and Frank Steuer. The platform connects business and luxury travelers with professional, vetted chauffeurs in 50+ countries and 250+ cities worldwide, offering airport transfers, hourly bookings, and intercity rides through web, mobile app, and B2B API integrations. Blacklane operates a marketplace model—working exclusively with licensed local chauffeur companies rather than owning its own fleet—enabling global coverage with local quality standards.\n\nBlacklane targets premium business travelers, high-net-worth individuals, and corporate travel managers. Its B2B API and white-label integrations are used by major airlines (Lufthansa, Qatar Airways), hotel concierge platforms, and travel management companies to offer seamless door-to-door ground transportation. The platform's carbon-neutral rides initiative and EV-first fleet direction resonated strongly with ESG-focused corporate clients.\n\nBlacklane raised $65 million in a Series G round in October 2024, bringing total funding to approximately $127M. Annual revenue reached approximately $75M as of late 2025, with a team of 630 employees across 6 continents. In a landmark exit, Blacklane was acquired by Uber on March 30, 2026, accelerating its integration into Uber's global premium ground transportation strategy.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.